Envista price target raised to $18 from $17 at Piper Sandler

Piper Sandler raised the firm’s price target on Envista (NVST) to $18 from $17 and keeps a Neutral rating on the shares. The firm is not expecting any major surprises from Envista as Q4 results seem likely to be fine, and Piper anticipates management to again point to evidence of progress in early turnaround efforts. The firm also expects the Envista team to remain measured with their tone and financial guidance, but finds itself aligning with the view that the path to accelerating revenue and improving margins may take longer than bulls think due to premium/higher-end areas of dentistry seeming likely to recover at a slower pace than general dentistry and value-leaning categories.